HIV Prevention and Care Interventions for Youth in Uganda
Status:
RECRUITING
Trial end date:
2028-08-31
Target enrollment:
Participant gender:
Summary
Several studies show that Adolescents and Young Adults (AYA) have poor outcomes along the entire Human Immunodeficiency Virus (HIV) prevention and care cascades compared to adults. The investigators propose to evaluate novel evidence-based HIV prevention and care interventions (including Cabotegravir LongActing (CABLA) to determine implementation outcomes among AYA who are at particularly high risk for HIV acquisition and poor viral suppression in five geographically distinct research performance sites in Uganda. The results will provide important evidence to inform Uganda and other regional countries' policy on integrated HIV prevention, care and treatment for AYA at high risk for HIV and Sexually Transmitted Infections (STIs) in order to reach the UNAIDS 95-95-95 targets and HIV epidemic control.
Phase:
PHASE4
Details
Lead Sponsor:
MU-JHU CARE
Collaborators:
Baylor College of Medicine Infectious Diseases Research Collaboration, Uganda Makerere University Joint AIDS Program University of California, San Francisco